Status:
COMPLETED
Treatment Effects of Atorvastatin on Hemostasis and Skin Microcirculation in Patients With Type 1 Diabetes
Lead Sponsor:
Karolinska Institutet
Conditions:
Type 1 Diabetes Mellitus
Dyslipidemia
Eligibility:
All Genders
30-70 years
Phase:
PHASE4
Brief Summary
Patients with type 1 diabetes are at increased risk of vascular complications both in the micro- and macrocirculation. Hyperglycemia plays a major role in the development of these vascular complicatio...
Eligibility Criteria
Inclusion
- type 1 diabetes
- level of plasma LDL-cholesterol \>2.5mmol/L and/or total cholesterol \>4.5mmol/L
Exclusion
- History of macrovascular events
Key Trial Info
Start Date :
January 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2010
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT01497912
Start Date
January 1 2005
End Date
January 1 2010
Last Update
December 23 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Karolinska Institutet, Department of Clinical Sciences, Danderyd Hospital
Stockholm, Sweden, 182 88